EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neurological Manifestations of Patients With CNS Metastases: Experience From a Single Center in an Upper-Middle-Income Country

Bernardo Cacho-Díaz iD, Alberto González-Aguilar, Gervith Reyes-Soto iD, José O Navarro-Fernández iD, Federico Maldonado-Magos, Oscar Arrieta iD, Talia Wegman-Ostrosky iD, Orwa Aboud iD, Mónica Serrano-Murillo

JCO Global Oncology · 2025

DOI: 10.1200/go-24-00465 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Bernardo Cacho-Díaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Neuro-Oncología, Instituto Nacional de Cancerología, Mexico City, Mexico. Hauptthemen laut MEDLINE: Brain Neoplasms, Nervous System Diseases, Central Nervous System Neoplasms. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE This study aimed to report the neurological manifestations of patients with CNS metastases (CNSm) and to determine their association with survival in patients with brain metastases (BrMs). MATERIALS AND METHODS A retrospective analysis of patients with CNSms (BrMs or neoplastic meningitis) seen at two referral centers between 2010 and 2022. The neurological manifestations and their association with survival were measured and presented. RESULTS Among 822 patients with CNSms, the most common neurological manifestations were headache, focal weakness, visual disorders, nausea/vomiting, seizures, and altered mental status (53%, 35%, 24%, 23%, 22%, and 18%, respectively). In patients with BrMs, neurological manifestations associated with survival were asymptomatic (hazard ratio [HR], 0.48 [95% CI, 0.31 to 0.73]; P = .001), focal weakness (HR, 1.26 [95% CI, 1.02 to 1.54]; P = .027), or visual disorders (HR, 1.26 [95% CI, 1.01 to 1.58]; P = .045). CONCLUSION Neurological manifestations in patients with BrMs are associated with survival and can aid in prognostic stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsNervous System DiseasesCentral Nervous System NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedPrognosis

Autor:innen und Institutionen

  • Unidad de Neuro-Oncología, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Neuro-Oncology Unit, Instituto Nacional de Neurología y Neurocirugía, México City, Mexico.
  • Subdirección de Radioterapia, Instituto Nacional de Cancerología, México City, Mexico.
  • Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, Mexico.
  • Research Unit, Instituto Nacional de Cancerología, México City, Mexico.
  • Department of Neurology, Neurological Surgery, and Comprehensive Cancer Center, University of California, Davis, Sacramento, CA.

ORCID-Profile: Bernardo Cacho-Díaz, Gervith Reyes-Soto, José O Navarro-Fernández, Oscar Arrieta, Talia Wegman-Ostrosky, Orwa Aboud

Zitieren

APA

Cacho-Díaz, B., González-Aguilar, A., Reyes-Soto, G., Navarro-Fernández, J. O., Maldonado-Magos, F., Arrieta, O., Wegman-Ostrosky, T., Aboud, O., & Serrano-Murillo, M. (2025). Neurological Manifestations of Patients With CNS Metastases: Experience From a Single Center in an Upper-Middle-Income Country. JCO Global Oncology. https://doi.org/10.1200/go-24-00465

Vancouver

Cacho-Díaz B, González-Aguilar A, Reyes-Soto G, Navarro-Fernández JO, Maldonado-Magos F, Arrieta O, et al. Neurological Manifestations of Patients With CNS Metastases: Experience From a Single Center in an Upper-Middle-Income Country. JCO Global Oncology. 2025. doi:10.1200/go-24-00465

BibTeX
@article{CachoDaz2025,
  author = {Cacho-Díaz, Bernardo and González-Aguilar, Alberto and Reyes-Soto, Gervith and Navarro-Fernández, José O and Maldonado-Magos, Federico and Arrieta, Oscar and Wegman-Ostrosky, Talia and Aboud, Orwa and Serrano-Murillo, Mónica},
  title = {Neurological Manifestations of Patients With CNS Metastases: Experience From a Single Center in an Upper-Middle-Income Country},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-24-00465}
}
Kostenlos starten →